What's inside this report?

• This report is an essential source for in-depth information and data relating to Country "Sector" industry . It also offers detailed and comprehensive coverage of industry revenue, volume, distribution and industry player share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the "Sector"in Country.

Scope of the Research

• The report provides segment information broken down into detailed categories and sectors in country.
• Total revenues, products sold, end users, and average pricing.
• Industry shares of all the key competitors.
• Key pipeline products that are set to shape the industry , broken down by segment .
• Information on the top medical equipment industry players in the segment in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, Research and Development projects , corporate growths and contractions and regulation modifications .
• Key M&A deals , partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the market at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the industry in the country.
• Identify growth sectors and opportunities in each market segment within the country.
• Evaluate the pipeline of key products that will change the segment , and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the industry in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the industry in the country.
• Identify and analyze the strengths and weaknesses of the market incumbents in the country.

Table Of Contents

Sector in Country Report
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Definitions
2.2.1 Neurology Devices
2.2.1.1 CSF (Cerebro Spinal Fluid) Management
2.2.1.2 Interventional Neurology
2.2.1.3 Neurostimulation Device
2.2.1.4 Neurosurgical Products
2.2.1.5 Radio surgery
3 Healthcare Segment Review
3.1 Healthcare Expenditure
3.2 Healthcare Infrastructure
3.2.1 Healthcare Personnel Data
3.2.2 Healthcare Facilities Data
3.3 Healthcare Policy
4 Neurology Devices in Netherlands
4.1 Neurology Devices Overall Revenues (from 2000 to 2012 )
4.2 Neurology Devices Overall Volumes (from 2000 to 2012 )
4.3 Neurology Devices Overall Firms Share (2005-2006)
5 CSF Management in Netherlands
5.1 CSF Management Overall Revenue (from 2000 to 2012 )
5.1.1 Hydrocephalus Shunts Overall Revenues (from 2000 to 2012 )
5.1.2 ICP Monitoring Devices Overall Revenues (from 2000 to 2012 )
5.2 CSF Management Overall Volume (from 2000 to 2012 )
5.2.1 Hydrocephalus Shunts Overall Volume (from 2000 to 2012 )
5.2.2 ICP Monitoring Devices Overall Volume (from 2000 to 2012 )
5.3 CSF Management Average Price (from 2000 to 2012 )
5.3.1 Hydrocephalus Shunts Average Price (from 2000 to 2012 )
5.3.2 ICP Monitoring Devices Average Price (from 2000 to 2012 )
5.4 CSF Management Distribution Share (2005-2006)
5.5 CSF Management Firms Share (2005-2006)
6 Radiosurgery in Netherlands
6.1 Radiosurgery Overall Revenue (from 2000 to 2012 )
6.1.1 GammaKnife Overall Revenues (from 2000 to 2007 )
6.2 Radiosurgery Overall Volume (from 2000 to 2012 )
6.2.1 CyberKnife Overall Volume (2007-2012)
6.2.2 GammaKnife Overall Volume (from 2000 to 2012 )
6.3 Radiosurgery Average Price (from 2000 to 2012 )
6.3.1 GammaKnife Average Price (from 2000 to 2012 )
6.4 Radiosurgery Distribution Share (2005-2006)
7 Neurostimulation Devices in Netherlands
7.1 Neurostimulation Devices Overall Revenue (from 2000 to 2012 )
7.1.1 Deep Brain Stimulator Overall Revenues (from 2000 to 2012 )
7.1.2 Spinal Cord Stimulator Overall Revenues (from 2000 to 2012 )
7.1.3 Vagus Nerve Stimulator Overall Revenues (from 2000 to 2012 )
7.2 Neurostimulation Devices Overall Volume (from 2000 to 2012 )
7.2.1 Spinal Cord Stimulator Overall Volume (from 2000 to 2012 )
7.2.2 Deep Brain Stimulator Overall Volume (from 2000 to 2012 )
7.2.3 Deep Brain Stimulator Overall Volume (from 2000 to 2012 )
7.3 Neurostimulation Devices Average Price (from 2000 to 2012 )
7.3.1 Spinal Cord Stimulator Average Price (from 2000 to 2012 )
7.3.2 Deep Brain Stimulator Average Price (from 2000 to 2012 )
7.3.3 Vagus Nerve Stimulator Average Price (from 2000 to 2012 )
7.4 Neurostimulation Devices Distribution Share (2005-2006)
7.5 Neurostimulation Devices Firms Share (2005-2006)
8 Interventional Neurology in Netherlands
8.1 Interventional Neurology Overall Revenue (from 2000 to 2012 )
8.1.1 Navigational System Overall Revenues (from 2000 to 2012 )
8.1.1.1 Navigational Catheters Overall Revenues (from 2000 to 2011 )
8.1.1.2 Guidewires Overall Revenues (from 2000 to 2011 )
8.1.2 Embolic System Overall Revenues (from 2000 to 2012 )
8.1.2.1 Embolization Coils Overall Revenues (from 2000 to 2011 )
8.1.2.2 Liquid Embolic Systems(Embolic Agent) Overall Revenues (from 2000 to 2011 )
8.1.3 Aneurism Clips Overall Revenues (from 2000 to 2012 )
8.2 Interventional Neurology Overall Volume (from 2000 to 2012 )
8.2.1 Embolic System Overall Volume (from 2000 to 2012 )
8.2.1.1 Liquid Embolic Systems (Embolic Agent) Overall Volume (from 2000 to 2011 )
8.2.1.2 Embolization Coils Overall Volume (from 2000 to 2011 )
8.2.2 Navigational System Overall Volume (from 2000 to 2012 )
8.2.3 Aneurism Clips Overall Volume (from 2000 to 2012 )
8.3 Interventional Neurology Average Price (from 2000 to 2012 )
8.3.1 Aneurism Clips Average Price (from 2000 to 2012 )
8.3.2 Embolic System Coils Average Price (from 2000 to 2012 )
8.3.2.1 Embolization Coils Average Price (from 2000 to 2012 )
8.3.2.2 Liquid Embolic Systems (Embolic Agent) Average Price (from 2000 to 2012 )
8.3.3 Navigational System Average Price (from 2000 to 2012 )
8.3.3.1 Guidewires Average Price (from 2000 to 2012 )
8.3.3.2 Navigational Catheters Average Price (from 2000 to 2012 )
8.4 Interventional Neurology Distribution Share (2005-2006)
8.5 Interventional Neurology Firms Share (2005-2012)
9 Neurosurgical Products in Netherlands
9.1 Neurosurgical Products Overall Revenue (from 2000 to 2012 )
9.2 Neurosurgical Products Overall Volume (from 2000 to 2012 )
9.3 Neurosurgical Products Average Price (from 2000 to 2012 )
9.3.1 Neuroendoscopes Average Price (from 2000 to 2012 )
9.4 Neurosurgical Products Distribution Share (2005-2006)
9.5 Neurosurgical Products Firms Share (2005-2006)
14 APPENDIX
14.1 Methodology
14.2 Currency Conversion
14.3 Contact Us
14.4 Disclaimer
Note: Some content types may not be available in this report

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.